Send to

Choose Destination
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S205-7.

DANBIO: a nationwide registry of biological therapies in Denmark.

Author information

DANBIO, Copenhagen University Hospital at Hvidovre, Department of Rheumatology, Hvidovre, Denmark.


Since the year 2000, Danish rheumatologists have been collecting data on a routine basis in the nationwide DANBIO registry, which includes all rheumatologic patients receiving biological drugs. Demographic data, markers of disease activity, current treatment, serious and non-serious adverse events and reasons for discontinuation are registered at each visit either on paper forms or on-line. By June 2005, approximately 3000 treatment courses (18,000 visits) were in the registry, corresponding to close to 90% of eligible patients. Rheumatoid arthritis was the most prevalent diagnosis (75%) followed by ankylosing spondylitis (11%) and psoriatic arthritis (7%). Infections occurred in 43% of the treatment series.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center